Xenon Pharmaceuticals Inc. has grown revenue −7.4% a year over three years and −25% a year over five. Revenue growth, 3-year annual rate: −7.4% (Biotechnology median +17%). Revenue growth, 5-year rate: −25%, growth has picked up over the last three years. Years of annual history on file: 14, FY2012 to FY2025, as filed.

XENEXenon Pharmaceuticals Inc.

Healthcare

$36.44-1.4% 1Y

$36.44

$36.1752 weeks$68.91

Is it growing?

Watch

Revenue shrinking (−100% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Revenue trend−100% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is XENE growing?

Xenon Pharmaceuticals Inc. has grown revenue −7.4% a year over three years and −25% a year over five.

−7.4%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −25%
Revenue growth, 5-year rate · −7.4% over three · growth has picked up over the last three years
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›